WHAT IS A biosimilar?
Let’s learn more about what biosimilars are and the process for developing them
WHAT DO biosimilars MEAN for ME?
Let’s explore how biosimilars may potentially expand treatment options to meet the growing demand for biologic therapies
WHAT iS Pfizer’s ROLE?
Let’s learn more about how Pfizer builds on its experience with biologics through Pfizer Biosimilars
biosimilars by the Numbers
Over 100 biologic products will lose patent or will have lost protections by 2022More
RAND corporation estimates biosimilars may lead to savings up to $150 billion in direct spending on biologic drugs between 2017 and 2026*More
*Based on an assumption of a biosimilar market share of 50% and biosimilar prices are 50% of the reference product.
Pfizer has nearly 11 years of biosimilars experience outside the USMore